Karl‐Erik Andersson

33.8k total citations · 2 hit papers
704 papers, 26.1k citations indexed

About

Karl‐Erik Andersson is a scholar working on Urology, Physiology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Karl‐Erik Andersson has authored 704 papers receiving a total of 26.1k indexed citations (citations by other indexed papers that have themselves been cited), including 405 papers in Urology, 131 papers in Physiology and 111 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Karl‐Erik Andersson's work include Urinary Bladder and Prostate Research (389 papers), Pelvic floor disorders treatments (106 papers) and Hormonal and reproductive studies (94 papers). Karl‐Erik Andersson is often cited by papers focused on Urinary Bladder and Prostate Research (389 papers), Pelvic floor disorders treatments (106 papers) and Hormonal and reproductive studies (94 papers). Karl‐Erik Andersson collaborates with scholars based in Sweden, United States and Denmark. Karl‐Erik Andersson's co-authors include Anders Mattiasson, Petter Hedlund, Christer Sjögren, Hans Hedlund, Anders Arner, Per Alm, Katarina Persson, Lori A. Birder, Alan J. Wein and Paul Abrams and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and Nature Medicine.

In The Last Decade

Karl‐Erik Andersson

689 papers receiving 25.0k citations

Hit Papers

Urinary Bladder Contracti... 2004 2026 2011 2018 2004 2013 200 400 600

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Karl‐Erik Andersson 15.1k 6.4k 4.2k 4.0k 3.9k 704 26.1k
Naoki Yoshimura 9.9k 0.7× 5.0k 0.8× 1.5k 0.4× 2.0k 0.5× 685 0.2× 507 14.7k
Christopher R. Chapple 21.6k 1.4× 16.3k 2.5× 1.5k 0.4× 1.1k 0.3× 2.5k 0.6× 743 27.7k
Robert M. Levin 7.2k 0.5× 2.0k 0.3× 2.6k 0.6× 2.1k 0.5× 1.2k 0.3× 522 13.0k
William D. Steers 5.4k 0.4× 3.1k 0.5× 783 0.2× 1.0k 0.3× 2.7k 0.7× 198 10.9k
Carlo Alberto Maggi 3.1k 0.2× 811 0.1× 8.9k 2.1× 6.6k 1.7× 882 0.2× 590 21.7k
Wayne J.G. Hellstrom 5.9k 0.4× 1.6k 0.3× 2.7k 0.7× 881 0.2× 8.4k 2.1× 542 20.1k
Per M. Hellström 1.0k 0.1× 687 0.1× 2.1k 0.5× 3.9k 1.0× 2.5k 0.6× 419 15.0k
Jacob Rajfer 3.6k 0.2× 671 0.1× 2.1k 0.5× 1.1k 0.3× 5.3k 1.3× 298 12.0k
Hunter C. Champion 1.0k 0.1× 390 0.1× 4.6k 1.1× 3.7k 0.9× 2.4k 0.6× 296 21.5k
Praveen Anand 1.4k 0.1× 927 0.1× 2.6k 0.6× 5.8k 1.5× 354 0.1× 237 15.0k

Countries citing papers authored by Karl‐Erik Andersson

Since Specialization
Citations

This map shows the geographic impact of Karl‐Erik Andersson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karl‐Erik Andersson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karl‐Erik Andersson more than expected).

Fields of papers citing papers by Karl‐Erik Andersson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karl‐Erik Andersson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karl‐Erik Andersson. The network helps show where Karl‐Erik Andersson may publish in the future.

Co-authorship network of co-authors of Karl‐Erik Andersson

This figure shows the co-authorship network connecting the top 25 collaborators of Karl‐Erik Andersson. A scholar is included among the top collaborators of Karl‐Erik Andersson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karl‐Erik Andersson. Karl‐Erik Andersson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fraser, Matthew O., Phillip P. Smith, Meghan G. Sullivan, et al.. (2020). Best practices for cystometric evaluation of lower urinary tract function in muriform rodents. Neurourology and Urodynamics. 39(6). 1868–1884. 24 indexed citations
3.
Butler, Daniel, Inès Ambite, K. Nagy, et al.. (2018). Neuroepithelial control of mucosal inflammation in acute cystitis. Scientific Reports. 8(1). 22 indexed citations
4.
Vahabi, Bahareh, Adrian Wagg, Peter Rosier, et al.. (2017). Can we define and characterize the aging lower urinary tract?—ICI‐RS 2015. Neurourology and Urodynamics. 36(4). 854–858. 14 indexed citations
5.
Johannesson, N., Karl‐Erik Andersson, B. Joelsson, & C. G. A. Persson. (2015). Relaxation of Lower .Esophageal Sphincter and Stimulation of Gastric Secretion and Diuresis by Antiasthmatic Xanthines. American Review of Respiratory Disease.
6.
Kim, Jae‐Hyun, Karl‐Erik Andersson, John D. Jackson, et al.. (2014). Downregulation of Metabolic Activity Increases Cell Survival Under Hypoxic Conditions: Potential Applications for Tissue Engineering. Tissue Engineering Part A. 20(15-16). 2265–2272. 21 indexed citations
7.
Yamaguchi, Osamu, Masanori Nomiya, & Karl‐Erik Andersson. (2013). Functional consequences of chronic bladder ischemia. Neurourology and Urodynamics. 33(1). 54–58. 103 indexed citations
8.
Andersson, Karl‐Erik & Karen D. McCloskey. (2013). Lamina propria: The functional center of the bladder?. Neurourology and Urodynamics. 33(1). 9–16. 104 indexed citations
9.
Andersson, Karl‐Erik, et al.. (2012). Common theme for drugs effective in overactive bladder treatment: Inhibition of afferent signaling from the bladder. International Journal of Urology. 20(1). 21–27. 23 indexed citations
10.
Bharadwaj, Shantaram, Guihua Liu, Yingai Shi, et al.. (2011). Characterization of Urine-Derived Stem Cells Obtained from Upper Urinary Tract for Use in Cell-Based Urological Tissue Engineering. Tissue Engineering Part A. 17(15-16). 2123–2132. 145 indexed citations
11.
Thüroff, J.W., Paul Abrams, Karl‐Erik Andersson, et al.. (2011). Guías EAU sobre incontinencia urinaria. Actas Urológicas Españolas. 35(7). 373–388. 51 indexed citations
12.
Ishizuka, Osamu, Tetsuya Imamura, Teruyuki Ogawa, et al.. (2010). Relation between expression of α 1 -adrenoceptor mRNAs in bladder mucosa and urodynamic findings in men with lower urinary tract symptoms. Scandinavian Journal of Urology and Nephrology. 45(1). 15–19. 23 indexed citations
13.
Burmeister, David M., Tamer Aboushwareb, Josh Tan, et al.. (2010). Early Stages of In Situ Bladder Regeneration in a Rodent Model. Tissue Engineering Part A. 16(8). 2541–2551. 26 indexed citations
14.
Andersson, Karl‐Erik, Kristijan H. Kahler, & Ursula Ebinger. (2007). Heart Rates in OAB Patients Prior to Initiation of Treatment with Antimuscarinics. Neurourology and Urodynamics. 1 indexed citations
15.
Lee, Tack, Petter Hedlund, Donald Newgreen, & Karl‐Erik Andersson. (2007). Urodynamic Effects of a Novel EP 1 Receptor Antagonist in Normal Rats and Rats With Bladder Outlet Obstruction. The Journal of Urology. 177(4). 1562–1567. 54 indexed citations
16.
Shen, Zhenxin, et al.. (1995). Lack of Neuronal Nitric Oxide Synthase in Nerve Fibers of Aganglionic Intestine. Journal of Pediatric Gastroenterology and Nutrition. 20(1). 49–53. 1 indexed citations
17.
Greeff, K. & Karl‐Erik Andersson. (1981). Pharmacokinetics and clinical pharmacology. Springer eBooks. 1 indexed citations
18.
Ulmsten, U., Karl‐Erik Andersson, & L. Wingerup. (1980). Treatment of premature labor with the calcium antagonist nifedipine. Archives of Gynecology and Obstetrics. 229(1). 1–5. 142 indexed citations
19.
Ulmsten, U., et al.. (1979). Trial of the calcium antagonist nifedipine in the treatment of primary dysmenorrhoea. Archives of Gynecology and Obstetrics. 227(2). 147–151. 28 indexed citations
20.
Andersson, Karl‐Erik & B Arner. (1971). Treatment of diabetes insipidus.. BMJ. 3(5766). 111.2–111. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026